We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
+11.3%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$52.3B
AUM Growth
+$4.34B
(+9%)
Cap. Flow
-$146M
Cap. Flow
% of AUM
-0.28%
Top 10 Holdings %
Top 10 Hldgs %
26.12%
Holding
2,277
New
427
Increased
521
Reduced
1,052
Closed
79
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IS
ironSource Ltd.
IS
|
+$136M |
| 2 |
Tesla
TSLA
|
+$119M |
| 3 |
Verizon
VZ
|
+$109M |
| 4 |
Home Depot
HD
|
+$101M |
| 5 |
Pfizer
PFE
|
+$88M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$247M |
| 2 |
Intel
INTC
|
+$216M |
| 3 |
Ford
F
|
+$145M |
| 4 |
General Motors
GM
|
+$143M |
| 5 |
Micron Technology
MU
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.15% |
| 2 | Healthcare | 14.97% |
| 3 | Financials | 14.22% |
| 4 | Consumer Discretionary | 11.15% |
| 5 | Communication Services | 8.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NXGN
1626
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $501K | ﹤0.01% |
28,174
-20,910
| -43% | -$336K |
|
|
HAPN
1627
Happen Inc
HAPN
$2.12B
| $499K | ﹤0.01% |
+20,620
| New | +$698K |
|
1628
Enova International
ENVA
$6.12B
| $496K | ﹤0.01% |
12,100
-24,700
| -67% | -$937K |
|
1629
HNI Corp
HNI
$3.08B
| $496K | ﹤0.01% |
11,793
-22,790
| -66% | -$913K |
|
1630
CVB Financial
CVBF
$4.01B
| $494K | ﹤0.01% |
23,072
-94,500
| -80% | -$1.94M |
|
1631
Kodiak Sciences
KOD
$2.47B
| $493K | ﹤0.01% |
+5,820
| New | +$592K |
|
1632
Northwest Bancshares
NWBI
$2.32B
| $493K | ﹤0.01% |
34,807
-95,020
| -73% | -$1.32M |
|
1633
CareDx
CDNA
$1.84B
| $492K | ﹤0.01% |
+10,810
| New | +$564K |
|
1634
PagerDuty
PD
$821M
| $492K | ﹤0.01% |
+14,150
| New | +$547K |
|
|
FLNA
1635
Filana Therapeutics
FLNA
$42.3M
| $492K | ﹤0.01% |
+11,250
| New | +$590K |
|
1636
John B. Sanfilippo & Son
JBSS
$983M
| $490K | ﹤0.01% |
5,433
-7,000
| -56% | -$600K |
|
1637
Huazhu Hotels Group
HTHT
$13.3B
| $487K | ﹤0.01% |
13,050
| – | – |
|
1638
Shift4
FOUR
$4.47B
| $485K | ﹤0.01% |
+8,380
| New | +$533K |
|
1639
Allegiant Air
ALGT
$2.63B
| $483K | ﹤0.01% |
2,581
-9,620
| -79% | -$1.79M |
|
1640
Riot Platforms
RIOT
$7.38B
| $483K | ﹤0.01% |
+21,650
| New | +$645K |
|
1641
Enviri
NVRI
$639M
| $481K | ﹤0.01% |
28,784
-39,770
| -58% | -$641K |
|
|
B
1642
DELISTED
Barnes Group Inc.
B
| $478K | ﹤0.01% |
10,262
-23,410
| -70% | -$1.03M |
|
|
CVGW
1643
DELISTED
Calavo Growers
CVGW
| $476K | ﹤0.01% |
11,232
-5,170
| -32% | -$212K |
|
1644
Dyne Therapeutics
DYN
$4.12B
| $476K | ﹤0.01% |
40,000
| – | – |
|
|
TDAY
1645
USA Today Co
TDAY
$1.3B
| $475K | ﹤0.01% |
89,070
-27,230
| -23% | -$152K |
|
|
CHUY
1646
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $474K | ﹤0.01% |
15,730
-20,270
| -56% | -$616K |
|
1647
Deluxe
DLX
$1.25B
| $473K | ﹤0.01% |
14,726
-24,310
| -62% | -$858K |
|
1648
Vanda Pharmaceuticals
VNDA
$299M
| $473K | ﹤0.01% |
30,160
-23,140
| -43% | -$403K |
|
1649
Herbalife
HLF
$1.28B
| $472K | ﹤0.01% |
+11,530
| New | +$480K |
|
1650
Standex International
SXI
$3.44B
| $471K | ﹤0.01% |
4,258
-6,860
| -62% | -$745K |
|
Similar funds
SCP
Ensign Peak Advisors's Q4 2021 Portfolio in Review
As of Q4 2021, Ensign Peak Advisors held 2,277 positions worth $52.3B, up 9% from $48B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Ensign Peak Advisors's Q4 2021 filing shows 427 new, 521 increased, 1,052 reduced and 79 closed positions. Its largest new stake was ironSource Ltd.: 13,801,563 shares worth $107M. The largest sale was AT&T, an estimated $247M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
- Ensign Peak Advisors's largest Q4 2021 buy was ironSource Ltd.: 13,801,563 shares worth $107M.
- Ensign Peak Advisors added most to Tesla in Q4 2021, an estimated $119M increase.
- Ensign Peak Advisors's biggest Q4 2021 reduction was AT&T, cutting an estimated $247M.
- Ensign Peak Advisors fully exited Acceleron Pharma in Q4 2021, selling an estimated $21.5M.
- Ensign Peak Advisors's ten largest holdings make up 26% of its $52.3B portfolio in Q4 2021.
- Ensign Peak Advisors opened 427 new positions and closed 79 in Q4 2021.
- Ensign Peak Advisors's portfolio value rose 9% quarter-over-quarter to $52.3B.
Based on Ensign Peak Advisors's 13F filing for Q4 2021, filed 11 Feb 2022.